Product logins

Find logins to all Clarivate products below.


Anna Somuyiwa

Head of the Centre for Innovation in Regulatory Science

Anna has over 19 years’ experience in Regulatory Affairs, having worked with various pharmaceutical companies and Clinical Research Organizations.

She is responsible for the Centre for Innovation in Regulatory Science (CIRS), a neutral, independent UK-based subsidiary of Clarivate plc. Her responsibilities include setting and delivering the research strategy with CIRS members, stakeholders, and CIRS staff.


arrow_forward
Get in touch with Anna

Latest news

News September 14, 2026
Clarivate and ODIN to Launch First Multi-State Resource Sharing Network Across the Dakotas

Rapido, Clarivate’s library resource sharing platform, to connect libraries across North and South Dakota, expanding access to collections London, U.K. September 14, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider…

News September 9, 2026
Clarivate Pulse of the Library 2026 Report Reveals AI Adoption Gaps Across Geographies, Mainland China Advancing Fastest

Organizational readiness, regional differences and evolving priorities are shaping the landscape of AI adoption in libraries London, U.K. September 9, 2026 – Clarivate Plc (NYSE:CLVT), a leading global provider of…

News August 26, 2026
Clarivate Updates Social Media Channels for Library Communities

Ex Libris and Innovative channels will become Clarivate for Academic Libraries and Clarivate for Public Libraries LONDON, UK, August 26, 2026 – Clarivate Plc (NYSE: CLVT), a leading global provider…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.